![](https://assets.weforum.org/article/image/xP5CJPca23HGWm02_7str8LBCzDB3XHap6-ii88C9CA.jpg)
Health and Healthcare Systems
How could an existing liver disease drug help reduce COVID cases?
Ursodeoxycholic acid (UDCA), targets a receptor called ACE2, which is the ‘doorway’ that SARS-CoV-2 uses to infect cells. It could help us fight COVID-19.